These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Challenges in developing drugs for neurological and psychiatric disorders. Simon NG; Brownstein MJ Prog Neurobiol; 2017 May; 152():1-2. PubMed ID: 28442128 [No Abstract] [Full Text] [Related]
8. [Psychiatry and human rights: welfare of the patient is in first place. Acceptance speech for the Juan Jose Lopez Award]. Eisenberg L Psychiatr Danub; 2009 Sep; 21(3):266-75. PubMed ID: 19794341 [No Abstract] [Full Text] [Related]
9. The extinction of drugs for clinical research: Can the ECNP medicines chest save them? Nutt D; Kilpatrick G; Hayes A Eur Neuropsychopharmacol; 2014 Apr; 24(4):487-90. PubMed ID: 24508534 [No Abstract] [Full Text] [Related]
10. Open innovation: share or die.. Talaga P Drug Discov Today; 2009 Nov; 14(21-22):1003-5. PubMed ID: 19778629 [No Abstract] [Full Text] [Related]
11. [Clinical trials in psychiatry: present status and prospects]. Azorin JM; Belzeaux R; Adida M Encephale; 2016 Dec; 42(6S):S1. PubMed ID: 28236985 [No Abstract] [Full Text] [Related]
12. [Open innovation for Japanese pharmaceutical companies]. Hoshino T Nihon Yakurigaku Zasshi; 2013 Oct; 142(4):184-9. PubMed ID: 24107523 [No Abstract] [Full Text] [Related]
14. The current state of drug discovery and what it might take to improve drug discovery outcomes and approval successes. Turner MJ Drug Discov Today; 2015 Aug; 20(8):917-9. PubMed ID: 26100736 [No Abstract] [Full Text] [Related]
15. [Open innovation and licensing in the pharmaceutical industry]. Yamasaki M Nihon Yakurigaku Zasshi; 2013 Jul; 142(1):28-31. PubMed ID: 23842225 [No Abstract] [Full Text] [Related]
16. Michael Rosenblatt. Nat Rev Drug Discov; 2016 Sep; 15(10):672. PubMed ID: 27681789 [No Abstract] [Full Text] [Related]
17. Ian Tomlinson. Tomlinson I Nat Rev Drug Discov; 2016 Mar; 15(3):154. PubMed ID: 26893183 [No Abstract] [Full Text] [Related]
18. The critical impact of time discounting on economic incentives to overcome the antibiotic market failure. Spellberg B; Sharma P; Rex JH Nat Rev Drug Discov; 2012 Feb; 11(2):168. PubMed ID: 22293569 [No Abstract] [Full Text] [Related]